PubRank

G Alexander Patterson

Author PubWeight™ 149.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 2008 4.70
2 Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006 2.69
3 Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest 2006 2.33
4 Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg 2002 2.19
5 Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010 2.06
6 Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004 1.95
7 De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 2008 1.95
8 Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol 2011 1.93
9 Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2002 1.86
10 Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg 2003 1.80
11 Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol 2009 1.74
12 Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol 2009 1.64
13 Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol 2005 1.61
14 Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 2007 1.54
15 Potential for detrimental hyperinflation after lung transplantation with application of negative pleural pressure to undersized lung grafts. J Thorac Cardiovasc Surg 2003 1.54
16 Sternoclavicular joint infection: a comparison of two surgical approaches. Ann Thorac Surg 2011 1.52
17 Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg 2005 1.52
18 A prospective evaluation of lung volume reduction surgery in 200 consecutive patients. Chest 2003 1.51
19 Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg 2004 1.50
20 Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg 2008 1.50
21 Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol 2003 1.50
22 Prevalence of benign disease in patients undergoing resection for suspected lung cancer. Ann Thorac Surg 2006 1.46
23 Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol 2003 1.46
24 The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation 2005 1.46
25 Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest 2013 1.42
26 Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant 2010 1.41
27 Nonoperative management of large tracheal injuries. J Thorac Cardiovasc Surg 2008 1.40
28 Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high-risk criterion. J Thorac Cardiovasc Surg 2004 1.39
29 Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant 2011 1.37
30 Outcomes after resection of giant emphysematous bullae. Ann Thorac Surg 2004 1.33
31 Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants. Am J Respir Cell Mol Biol 2007 1.33
32 Bronchial fenestration improves expiratory flow in emphysematous human lungs. Ann Thorac Surg 2003 1.32
33 Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg 2010 1.32
34 Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J Immunol 2006 1.31
35 Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant 2005 1.31
36 Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology. Nat Protoc 2009 1.30
37 Lymph node evaluation in video-assisted thoracoscopic lobectomy versus lobectomy by thoracotomy. Ann Thorac Surg 2010 1.29
38 Effects of CT section thickness and reconstruction kernel on emphysema quantification relationship to the magnitude of the CT emphysema index. Acad Radiol 2010 1.26
39 Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg 2008 1.24
40 Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. J Thorac Cardiovasc Surg 2006 1.24
41 Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 2002 1.21
42 A simple, reproducible, and inexpensive technique in the preparation of explanted emphysematous lungs for ex vivo studies. J Thorac Cardiovasc Surg 2005 1.16
43 Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center. J Thorac Cardiovasc Surg 2010 1.15
44 CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants. J Immunol 2008 1.14
45 Outcomes and perception of lung surgery with implementation of a patient video education module: a prospective cohort study. J Am Coll Surg 2012 1.13
46 Use of an apical heart suction device for exposure in lung transplantation. Ann Thorac Surg 2006 1.13
47 Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival. Ann Thorac Surg 2011 1.12
48 Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant 2004 1.10
49 Oxidative damage to nucleic acids in severe emphysema. Chest 2008 1.10
50 Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database. Ann Thorac Surg 2013 1.10
51 Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant 2004 1.09
52 Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761. J Thorac Cardiovasc Surg 2002 1.08
53 Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg 2005 1.06
54 Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer 2005 1.05
55 National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer. J Thorac Oncol 2014 1.05
56 Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant 2008 1.05
57 A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. J Thorac Cardiovasc Surg 2011 1.03
58 Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg 2004 1.03
59 Comparison of open subxiphoid pericardial drainage with percutaneous catheter drainage for symptomatic pericardial effusion. Ann Thorac Surg 2003 1.03
60 Feasibility and safety of the airway bypass procedure for patients with emphysema. J Thorac Cardiovasc Surg 2003 1.02
61 Macrophage chitinase 1 stratifies chronic obstructive lung disease. Am J Respir Cell Mol Biol 2009 1.02
62 Cigarette smoke induces nucleic-acid oxidation in lung fibroblasts. Am J Respir Cell Mol Biol 2009 1.01
63 Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells. Transplantation 2002 1.00
64 IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med 2006 1.00
65 Treatment of malignant pleural effusion: a cost-effectiveness analysis. Ann Thorac Surg 2012 0.99
66 Reliability for grading acute rejection and airway inflammation after lung transplantation. J Heart Lung Transplant 2005 0.98
67 Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection. Ann Thorac Surg 2010 0.98
68 Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Ann Thorac Surg 2002 0.97
69 The predictive value of bronchiolitis obliterans syndrome stage 0-p. Am J Respir Crit Care Med 2003 0.97
70 Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency. Am J Transplant 2005 0.97
71 Endobronchial gene transfer of soluble type I interleukin-1 receptor ameliorates lung graft ischemia-reperfusion injury. Ann Thorac Surg 2004 0.96
72 Effects of diffusion time on short-range hyperpolarized (3)He diffusivity measurements in emphysema. J Magn Reson Imaging 2009 0.95
73 Adult lung transplantation: technical considerations. Semin Thorac Cardiovasc Surg 2008 0.95
74 Primary graft dysfunction and other selected complications of lung transplantation: A single-center experience of 983 patients. J Thorac Cardiovasc Surg 2005 0.94
75 Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 2006 0.93
76 Orthotopic vascularized right lung transplantation in the mouse. J Thorac Cardiovasc Surg 2010 0.93
77 Completion pneumonectomy: outcomes for benign and malignant indications. Ann Thorac Surg 2013 0.93
78 Concomitant allorecognition of mismatched donor HLA class I- and class II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003 0.92
79 Concomitant coronary artery revascularization to allow successful lung transplantation in selected patients with coronary artery disease. J Thorac Cardiovasc Surg 2002 0.92
80 Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 2010 0.92
81 Impact of video-assisted thoracoscopic surgery on benign resections for solitary pulmonary nodules. Ann Thorac Surg 2011 0.92
82 Clinical-pathologic conference in general thoracic surgery: Cardiac lymphoma. J Thorac Cardiovasc Surg 2005 0.91
83 Intralobar pulmonary sequestration associated with an aneurysmal aberrant aortic branch. J Thorac Cardiovasc Surg 2007 0.91
84 Tumor location is not an independent prognostic factor in early stage non-small cell lung cancer. Ann Thorac Surg 2010 0.90
85 Technical considerations in lung transplantation. Chest Surg Clin N Am 2003 0.90
86 A positive return on investment: research funding by the Thoracic Surgery Foundation for Research and Education (TSFRE). J Thorac Cardiovasc Surg 2011 0.89
87 Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients. J Heart Lung Transplant 2010 0.88
88 Lung transplantation and donation after cardiac death: a single center experience. Ann Thorac Surg 2009 0.88
89 Lung transplantation for pulmonary vascular disease. Ann Thorac Surg 2002 0.88
90 Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial. Lung Cancer 2005 0.88
91 Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation. Hum Immunol 2010 0.88
92 Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow. J Heart Lung Transplant 2005 0.87
93 Does the presence of preoperative mild or moderate coronary artery disease affect the outcomes of lung transplantation? Ann Thorac Surg 2006 0.86
94 Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome. Transplantation 2004 0.86
95 Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy. J Thorac Oncol 2015 0.84
96 Down-regulation of beta catenin inhibits the growth of esophageal carcinoma cells. J Thorac Cardiovasc Surg 2004 0.84
97 Performance of integrated positron emission tomography/computed tomography for mediastinal nodal staging in non-small cell lung carcinoma. Thorac Surg Clin 2013 0.84
98 Massive bilateral chylothoraces complicating mediastinal granulomatous disease. Ann Thorac Surg 2009 0.83
99 A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. J Heart Lung Transplant 2007 0.83
100 Role of airway epithelial injury in murine orthotopic tracheal allograft rejection. Ann Thorac Surg 2006 0.83
101 Technical considerations in adult lung transplantation. Semin Thorac Cardiovasc Surg 2004 0.83
102 Bilateral lung transplantation and pulmonary artery reconstruction in a patient with chronic obstructive pulmonary disease and a giant pulmonary artery aneurysm. J Thorac Cardiovasc Surg 2003 0.81
103 In vivo molecular imaging characterizes pulmonary gene expression during experimental lung transplantation. Am J Transplant 2005 0.81
104 Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation. J Heart Lung Transplant 2004 0.81
105 Retrograde jejunogastric decompression after esophagectomy is superior to nasogastric drainage. Ann Thorac Surg 2011 0.81
106 Recipient intramuscular cotransfection of naked plasmid transforming growth factor beta1 and interleukin 10 ameliorates lung graft ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2002 0.81
107 Does donor cause of death affect the outcome of lung transplantation? J Thorac Cardiovasc Surg 2002 0.81
108 A comparison of basiliximab and anti-thymocyte globulin as induction agents after lung transplantation. J Heart Lung Transplant 2005 0.80
109 Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts. Transplantation 2002 0.80
110 Clinical-pathologic conference in general thoracic surgery: pulmonary blastoma. J Thorac Cardiovasc Surg 2003 0.80
111 Critical care aspects of lung transplantation. J Intensive Care Med 2004 0.80
112 Lung transplantation in children. Ann Surg 2002 0.80
113 Extrapleural pneumonectomy complicated by acute superior mesenteric artery syndrome. Ann Thorac Surg 2012 0.80
114 Recipient intramuscular cotransfection of transforming growth factor beta1 and interleukin 10 ameliorates acute lung graft rejection. J Thorac Cardiovasc Surg 2005 0.79
115 Non solus--a leadership challenge. J Thorac Cardiovasc Surg 2010 0.79
116 Living donor lobar grafts improve pediatric lung retransplantation survival. J Thorac Cardiovasc Surg 2006 0.78
117 A thoracic surgery clinic dedicated to indeterminate pulmonary nodules: too many scans and too little pathology? J Thorac Cardiovasc Surg 2009 0.78
118 Outcome of lung transplantation for patients requiring concomitant cardiac surgery. J Thorac Cardiovasc Surg 2005 0.78
119 Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection. J Heart Lung Transplant 2012 0.78
120 The feasibility of diaphragmatic transplantation as potential therapy for treatment of respiratory failure associated with Duchenne muscular dystrophy: acute canine model. J Thorac Cardiovasc Surg 2008 0.77
121 Intratracheal adenovirus-mediated gene transfer is optimal in experimental lung transplantation. J Thorac Cardiovasc Surg 2002 0.77
122 Pulmonary cement embolization after vertebroplasty requiring pulmonary wedge resection. Clin Orthop Relat Res 2014 0.77
123 Adenovirus encoding soluble tumor necrosis factor alpha receptor immunoglobulin prolongs gene expression of a cotransfected reporter gene in rat lung. J Thorac Cardiovasc Surg 2003 0.77
124 Intramuscular gene transfer of interleukin-10 reduces neutrophil recruitment and ameliorates lung graft ischemia-reperfusion injury. Am J Transplant 2002 0.77
125 Clinical-pathologic conference in general thoracic surgery: malignant transformation of recurrent respiratory papillomatosis. J Thorac Cardiovasc Surg 2005 0.77
126 Recipient intramuscular administration of naked plasmid TGF-beta1 attenuates lung graft reperfusion injury. J Heart Lung Transplant 2003 0.77
127 Emphysema quantification in inflation-fixed lungs using low-dose computed tomography and 3He magnetic resonance imaging. J Comput Assist Tomogr 2010 0.76
128 Thrombotic microangiopathy after lung transplantation. Transplantation 2006 0.76
129 Lung transplantation in India: a possible treatment option. Natl Med J India 2009 0.76
130 Concomitant lung cancer resection and lung volume reduction surgery. Thorac Surg Clin 2009 0.76
131 Impact of anastomotic techniques on airway complications after lung transplant. Ann Thorac Surg 2011 0.76
132 Dysphagia in the young male: the ringed esophagus. Ann Thorac Surg 2006 0.75
133 Hiatal hernia repair with or without esophageal lengthening: is there a difference? Innovations (Phila) 2013 0.75
134 Living lobar lung transplantation: is it a necessary option? Am J Transplant 2004 0.75
135 Quantitative Computed Tomography Classification of Lung Nodules: Initial Comparison of 2- and 3-Dimensional Analysis. J Comput Assist Tomogr 2016 0.75
136 Special article: physiologic consequences of pneumonectomy. Consequences on the esophageal function. 1999. Chest Surg Clin N Am 2002 0.75
137 Editorial comment: Merits of cadaveric lobar lung transplantation. Eur J Cardiothorac Surg 2012 0.75
138 Single-lung transplantation in the setting of aborted bilateral lung transplantation. J Transplant 2011 0.75
139 Infectious necrotizing esophagitis: outcome after medical and surgical intervention. Ann Thorac Surg 2003 0.75
140 Tumor necrosis factor inhibitor gene transfer ameliorates lung graft ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2003 0.75
141 Partial lobar torsion secondary to traumatic hemothorax. J Thorac Cardiovasc Surg 2008 0.75
142 Joint statement on redundant (duplicate) publication by the Editors of the undersigned cardio-thoracic journals. Eur J Cardiothorac Surg 2015 0.75
143 Joint statement on redundant (duplicate) publication by the Editors of the undersigned cardiothoracic journals. J Thorac Cardiovasc Surg 2015 0.75
144 Editor's Commentary. Ann Thorac Surg 2017 0.75
145 Joint statement on redundant (duplicate) publication by the Editors of the undersigned cardio-thoracic journals. Asian Cardiovasc Thorac Ann 2015 0.75
146 Gene transfer of tumor necrosis factor inhibitor improves the function of lung allografts. J Thorac Cardiovasc Surg 2004 0.75
147 Clinical-pathologic conference in general thoracic surgery: carinal resection for endobronchial grade I neuroendocrine carcinoma. J Thorac Cardiovasc Surg 2006 0.75
148 Handheld office-based spirometry versus laboratory spirometry in low-risk patients undergoing lung resection. Innovations (Phila) 2011 0.75
149 Effect of a cardiac-specific didactic course on thoracic surgery in-training examination performance. Ann Thorac Surg 2003 0.75
150 Reaching Forward. Ann Thorac Surg 2015 0.75
151 Myocardial metastasis or benign brown fat? Circ Cardiovasc Imaging 2009 0.75
152 Fibrovascular polyps of the esophagus. J Thorac Cardiovasc Surg 2005 0.75
153 Outcomes after unilateral lung volume reduction. Ann Thorac Surg 2008 0.75
154 Recurrent subcutaneous air of the face and neck. Ann Thorac Surg 2010 0.75
155 Lung transplantation at Barnes-Jewish Hospital and Washington University in St. Louis. Clin Transpl 2010 0.75
156 Mycotic pulmonary artery pseudoaneurysm. J Thorac Imaging 2005 0.75
157 Low-dose endobronchial gene transfer to ameliorate lung graft ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2002 0.75
158 Video-assisted thoracoscopic surgery with posterior spinal reconstruction for the resection of upper lobe lung tumors involving the spine. Spine J 2013 0.75
159 Anatomic distortion of the right coronary artery as a complication of lung transplantation. Ann Thorac Surg 2010 0.75